Guilherme Harada

Brief Report: Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy

Or Kalchiem‐Dekel, Christina J. Falcon, Christine M. Bestvina et al. · Journal of Thoracic Oncology · 2022 · 42 citations · Full text

Molecular Pharmacology, Medicine, Brief Report +4

Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of <i>EGFR</i> -Mutant and <i>RET</i> Fusion-Positive Lung Cancers

Julia Rotow, Jyoti D. Patel, Matthew P. Hanley et al. · Clinical Cancer Research · 2023 · 40 citations · Full text

Brief Report: Tyrosine Kinase Inhibitors for Lung Cancers That Inhibit MATE-1 Can Lead to “False” Decreases in Renal Function

Monica F. Chen, Guilherme Harada, Dazhi Liu et al. · Journal of Thoracic Oncology · 2023 · 29 citations · Full text

Urology, Renal Function, Medicine +7

ALK Inhibitors in Patients With ALK Fusion–Positive GI Cancers: An International Data Set and a Molecular Case Series

Margherita Ambrosini, Marzia Del Re, Paolo Manca et al. · JCO Precision Oncology · 2022 · 28 citations · Full text

Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores

S.C. Reis-Alves, Fabı́ola Traina, Guilherme Harada et al. · PLoS ONE · 2013 · 25 citations · Full text